Explain the energetics of oxidative phosphorylation

Reading File

Finding Sources

Searching Images

oxidative phosphorylation electron transport chain ATP synthesis diagram

A two-part medical illustration depicting mitochondrial oxidative phosphorylation and the broader landscape of reactive oxygen species (ROS) biology. Section (a) shows the electron transport chain (ETC) within the inner mitochondrial membrane, detailing complexes I-IV, ubiquinone (Q), and cytochrome c. It illustrates electron flow from NADH/FADH2 leading to proton pumping into the intermembrane space and ATP synthesis via ATP synthase. The diagram highlights 'leaky' electrons from complexes I and III reacting with O2 to form superoxide (O2•-), which is subsequently neutralized by superoxide dismutase (SOD) and glutathione peroxidase (GPX). Section (b) outlines cellular and external ROS sources, including NADPH oxidase, peroxisomes, radiation, and pathogens. It demonstrates the dual nature of ROS: contributing to pathological oxidative stress (DNA damage, lipid oxidation, protein oxidation) leading to diseases like vascular disorders and neurodegeneration, while simultaneously acting as essential mediators in physiological redox signaling for cell growth, proliferation, apoptosis, and differentiation.

A pathophysiology diagram illustrating the mitochondrial oxidative phosphorylation (OXPHOS) system and its therapeutic inhibitors. The top schematic shows the inner mitochondrial membrane containing the Electron Transport Chain (ETC) complexes I through IV, Coenzyme Q (CoQ), and Cytochrome c (Cyt c), alongside ATP synthase (Complex V). It depicts the flow of electrons (2e-) from NADH and FADH2, the pumping of protons (H+) into the intermembrane space, and the final reduction of oxygen to water. Complex V is shown utilizing the proton gradient to convert ADP to ATP. The lower section identifies two pharmacological strategies for ATP depletion in cancer cells: 'Targeting OXPHOS complexes' using drugs like Pyrvinium pamoate, Atovaquone, Niclosamide, and Irinotecan; and 'Targeting Mitochondrial Biogenesis' using antibiotics such as Doxycycline, Tigecycline, and Azithromycin. Inhibitory arrows indicate these drugs disrupt mitochondrial function to target cancer stem cells (CSCs).

This pathophysiology diagram illustrates mitochondrial bioenergetics, specifically the electron transport chain (ETC), ATP synthesis, and the generation of reactive oxygen/nitrogen species (ROS/RNS). The upper portion details the inner mitochondrial membrane containing Complexes I through V. Complex I (NADH ubiquinone reductase) and Complex II (Succinate dehydrogenase) receive electrons from NADH and FADH2, respectively. Electrons flow through ubiquinone (CoQ) and cytochrome c (Cyt c) to Complex IV (Cytochrome c oxidase), which reduces O2 to H2O. Complexes I, III, and IV pump protons (H+) into the intermembrane space, creating a gradient that drives Complex V (F0F1 ATP Synthase) to convert ADP + Pi into ATP. ATP then exits to the cytosol via the VDAC channel. The lower section depicts oxidative stress pathways: O2 is converted to superoxide (•O2-) by oxidases or mitochondrial leakage. Superoxide is neutralized by Superoxide Dismutase (SOD) into H2O2, which Catalase (CAT) or the GSH/GSSG cycle converts to water. Alternatively, superoxide reacts with NO to form peroxynitrite (ONOO-) or leads to hydroxyl radicals (•OH), resulting in oxidative damage, mtDNA mutations, and mitochondrial dysfunction.

Reading File

Loading Image

I now have comprehensive material to write a thorough answer. Here it is:

Energetics of Oxidative Phosphorylation

Oxidative phosphorylation (OXPHOS) is the process by which the cell converts the chemical energy stored in reduced electron carriers (NADH, FADH2) into the high-energy phosphate bonds of ATP. It takes place at the inner mitochondrial membrane and couples two physically distinct but thermodynamically linked processes: electron transport and ATP synthesis.

Oxidative phosphorylation - electron transport chain and ATP synthase

1. Thermodynamic Foundation

Free Energy (DeltaG)

All spontaneous biological processes are driven by a decrease in Gibbs free energy. As stated in Lippincott's Biochemistry (8th ed.), the relationship is:

DeltaG = DeltaH - T*DeltaS

A negative DeltaG means the reaction is exergonic (spontaneous; energy is released).
A positive DeltaG means the reaction is endergonic (energy must be supplied).
DeltaG = 0 means the system is at equilibrium.

The actual DeltaG at any moment depends on both the intrinsic DeltaG° (standard free energy change, at 1 mol/L, pH 7) and the actual ratio of products to reactants:

DeltaG = DeltaG° + RT ln([Products]/[Reactants])

Reduction Potentials and DeltaG

Electron transfer reactions are governed by standard reduction potentials (E°'), measured in volts. A component with a more negative E°' is a better electron donor; one with a more positive E°' is a better electron acceptor. The overall free energy released when electrons pass from one redox couple to another is:

DeltaG°' = -n * F * DeltaE°'

Where:

n = number of electrons transferred
F = Faraday's constant (23.06 kcal/V·mol or 96,485 J/V·mol)
DeltaE°' = difference in standard reduction potentials

This is the thermodynamic driver of the entire electron transport chain. As electrons flow from NADH (E°' = -0.32 V) down to O2 (E°' = +0.82 V), the total DeltaE°' across the chain is approximately +1.14 V, releasing roughly 52.6 kcal/mol - sufficient to drive multiple rounds of ATP synthesis.

2. The Electron Transport Chain (ETC)

The ETC is a series of protein complexes embedded in the inner mitochondrial membrane. Electrons flow "downhill" in terms of reduction potential, with free energy being captured at three coupling sites to pump protons.

Electron Carriers and Their Order

Carrier	Accepts/Donates	Location
NADH	2e- (hydride)	Matrix
FMN (in Complex I)	2e-	Membrane
Fe-S centers	1e- at a time	Membrane
Coenzyme Q (CoQ/Ubiquinone)	1 or 2 e-	Membrane lipid
Cytochrome b, c1 (Complex III)	1e- via Fe2+/Fe3+	Membrane
Cytochrome c	1e-	Intermembrane space
Cytochromes a, a3 (Complex IV)	1e- + Cu	Membrane
O2	Final acceptor (4e- → 2 H2O)	Matrix

Complex II (succinate dehydrogenase) accepts electrons from FADH2 and feeds them into CoQ, but it does not pump protons - hence FADH2 yields less ATP than NADH.

Proton Pumping at Each Complex

As described in Basic Medical Biochemistry, 6th ed.:

Complex I: pumps 4 H+ per 2 electrons from NADH to CoQ
Complex III: pumps 4 H+ per 2 electrons from CoQH2 to cytochrome c (via the Q-cycle)
Complex IV: pumps 2 H+ per 2 electrons from cytochrome c to O2

Total protons pumped per NADH: 10 H+ into the intermembrane space.

3. The Proton Motive Force (Dp)

Proton pumping creates an electrochemical gradient (the proton motive force, Dp) across the inner mitochondrial membrane, which is impermeable to protons by itself. This gradient has two components:

Membrane potential (DeltaPsi): the electrical component, with the matrix side negatively charged (roughly -180 mV)
pH gradient (DeltapH): the chemical component, with the matrix more alkaline than the intermembrane space

Together these drive protons back into the matrix through ATP synthase. The inner membrane must remain proton-impermeable for this gradient to be maintained - any leak (uncoupling) dissipates the gradient as heat.

4. ATP Synthase (Complex V)

ATP synthase (F0F1-ATPase) is a molecular motor that harnesses the proton motive force. It has two structural components:

F0 (membrane subunit): contains the proton channel/pore spanning the inner membrane
F1 (matrix headpiece): contains the catalytic sites that synthesize ATP from ADP + Pi

As protons flow down their gradient through F0, they cause rotation of the gamma subunit, which changes the conformation of three catalytic beta subunits on F1 in a sequential pattern (the binding change mechanism of Paul Boyer):

Open (O) - binds ADP and Pi loosely
Loose (L) - ADP + Pi bound but not yet converted
Tight (T) - conformational change synthesizes and traps ATP

It takes approximately 3 protons to synthesize 1 ATP at the F1 head. With additional energy consumed by the phosphate transporter and adenine nucleotide translocase (ANT) that export ATP and import ADP/Pi, the real cost is roughly 3.67 H+ per ATP synthesized and exported.

5. ATP Yield

Modern measurements give the following yields (replacing the older "P/O ratios"):

Electron donor	H+ pumped	ATP yield
NADH	10 H+	~2.5 ATP
FADH2 (via Complex II)	6 H+	~1.5 ATP

This means for every mole of NADH oxidized, ~2.5 mol ATP are synthesized; for every mole of FADH2, ~1.5 mol. These values are lower than the old textbook figures of 3 and 2, respectively, because the proton cost of transporting ATP out of the mitochondria is now included.

For complete oxidation of one molecule of glucose (including glycolysis, pyruvate dehydrogenase, and TCA cycle):

10 NADH x 2.5 = 25 ATP
2 FADH2 x 1.5 = 3 ATP
4 ATP from substrate-level phosphorylation
Total: ~30-32 ATP per glucose (net)

For complete oxidation of pyruvate through the TCA cycle alone, the yield is ~12.5 ATP per pyruvate (from 4 NADH, 1 FADH2, and 1 GTP), as described in Basic Medical Biochemistry, 6th ed..

6. Coupling and Regulation

The ETC and ATP synthesis are tightly coupled via the proton gradient. Regulation is largely governed by the availability of ADP:

When cellular energy demand rises, ADP accumulates. This drives proton flux through ATP synthase, which collapses the gradient slightly, which in turn accelerates electron transport to restore Dp. This is known as respiratory control.
Conversely, when ATP is abundant and ADP is low, the gradient builds up, slowing electron transport.

Uncoupling

When the inner mitochondrial membrane is made permeable to protons by uncouplers (e.g., 2,4-dinitrophenol, DNP; fatty acids; or the endogenous protein thermogenin/UCP1 in brown fat), protons re-enter the matrix without passing through ATP synthase. The gradient dissipates as heat rather than ATP. Physiologically, this is how brown adipose tissue generates body heat. Pharmacologically, DNP was once used as a weight-loss agent and caused fatal hyperthermia.

Chemical Inhibitors

Inhibitor	Target	Effect
Rotenone, amytal	Complex I	Block NADH oxidation
Antimycin A	Complex III	Block electron flow to cytochrome c
Cyanide, CO	Complex IV	Prevent O2 reduction
Oligomycin	F0 of ATP synthase	Block proton channel
Atractyloside	ANT translocase	Block ADP/ATP exchange
DNP	Inner membrane	Proton uncoupler

7. Clinical Relevance

OXPHOS diseases (mitochondrial myopathies): mutations in mtDNA or nuclear DNA encoding ETC subunits reduce ATP capacity. Symptoms include myopathy, encephalopathy, and lactic acidosis (Kearns-Sayre syndrome, MELAS, MERRF).
Ischemia/reperfusion injury: lack of O2 halts electron flow and ATP production. When O2 returns, the sudden burst of electron transport generates reactive oxygen species (ROS).
Doxorubicin cardiotoxicity: the anthracycline binds cardiolipin in the inner mitochondrial membrane, inhibits Complex IV and ATP synthase, and generates free radicals, leading to mitochondrial damage and cardiomyopathy.
Cyanide poisoning: cyanide binds tightly to cytochrome c oxidase (Complex IV), preventing O2 reduction and halting the entire chain. All tissues (especially CNS and heart) become acutely ATP-depleted.

Summary

Step	Energy Currency
Fuel oxidation (glycolysis, TCA)	NADH, FADH2 produced
ETC electron flow	Proton gradient (Dp) built
ATP synthase	Dp converted to ATP

The elegance of OXPHOS is that it converts thermochemically unfavorable, stepwise oxidations into an electrochemical gradient that serves as a universal energy currency buffer, which is then used on demand to regenerate ATP - the cell's immediate fuel.

Sources:

Basic Medical Biochemistry: A Clinical Approach, 6th ed., Chapter 24 (Oxidative Phosphorylation and Mitochondrial Function)
Biochemistry, 8th ed. - Lippincott Illustrated Reviews, Chapter 6 (Bioenergetics and Oxidative Phosphorylation)

This is a shared conversation. Sign in to Orris to start your own chat.